4-[[(1R)-1-(carboxymethyl)-2-[4-(3-chloro-5-fluorophenyl)phenyl]ethyl]amino]-4-oxobutanoic acid

ID: ALA4459630

PubChem CID: 59607723

Max Phase: Preclinical

Molecular Formula: C20H19ClFNO5

Molecular Weight: 407.83

Molecule Type: Unknown

This compound is available for customization.

Associated Items:

Names and Identifiers

Canonical SMILES:  O=C(O)CCC(=O)N[C@@H](CC(=O)O)Cc1ccc(-c2cc(F)cc(Cl)c2)cc1

Standard InChI:  InChI=1S/C20H19ClFNO5/c21-15-8-14(9-16(22)10-15)13-3-1-12(2-4-13)7-17(11-20(27)28)23-18(24)5-6-19(25)26/h1-4,8-10,17H,5-7,11H2,(H,23,24)(H,25,26)(H,27,28)/t17-/m1/s1

Standard InChI Key:  SLSSIFQQORPRSK-QGZVFWFLSA-N

Molfile:  

 
     RDKit          2D

 28 29  0  0  0  0  0  0  0  0999 V2000
    4.7835   -2.3814    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.6048   -2.3814    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.0156   -3.0955    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.8362   -3.0959    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.2456   -2.3835    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.8326   -1.6693    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.0134   -1.6725    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.0632   -2.3834    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.4762   -3.0963    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.2968   -3.0956    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.7053   -2.3827    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.2913   -1.6690    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.4721   -1.6733    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.3749   -3.0932    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.5535   -3.0932    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.7835   -3.8051    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    4.3749   -4.5169    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.7835   -5.2288    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.5535   -4.5169    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    4.3749   -5.9406    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.7835   -6.6524    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.3749   -7.3601    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    5.6048   -6.6524    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    3.1449   -2.3855    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.3278   -2.3855    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    3.5535   -1.6778    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    9.7069   -3.8024    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
    9.6974   -0.9599    0.0000 Cl  0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  2  0
  3  4  1  0
  4  5  2  0
  5  6  1  0
  6  7  2  0
  7  2  1  0
  8  9  2  0
  9 10  1  0
 10 11  2  0
 11 12  1  0
 12 13  2  0
 13  8  1  0
  5  8  1  0
 14  1  1  1
 14 15  1  0
 14 16  1  0
 16 17  1  0
 17 18  1  0
 17 19  2  0
 18 20  1  0
 20 21  1  0
 21 22  1  0
 21 23  2  0
 15 24  1  0
 24 25  2  0
 24 26  1  0
 10 27  1  0
 12 28  1  0
M  END

Associated Targets(Human)

MME Tclin Neprilysin (838 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 407.83Molecular Weight (Monoisotopic): 407.0936AlogP: 3.51#Rotatable Bonds: 9
Polar Surface Area: 103.70Molecular Species: ACIDHBA: 3HBD: 3
#RO5 Violations: HBA (Lipinski): 6HBD (Lipinski): 3#RO5 Violations (Lipinski):
CX Acidic pKa: 3.84CX Basic pKa: CX LogP: 3.20CX LogD: -2.86
Aromatic Rings: 2Heavy Atoms: 28QED Weighted: 0.59Np Likeness Score: -0.61

References

1. Kawanami T, Karki RG, Cody E, Liu Q, Liang G, Ksander GM, Rigel DF, Schiering N, Gong Y, Coppola GM, Iwaki Y, Sun R, Neubert A, Fan L, Ingles S, D'Arcy A, Villard F, Ramage P, Jeng AY, Leung-Chu J, Liu J, Beil M, Fu F, Chen W, Cumin F, Wiesmann C, Mogi M..  (2020)  Structure-Guided Design of Substituted Biphenyl Butanoic Acid Derivatives as Neprilysin Inhibitors.,  11  (2): [PMID:32071687] [10.1021/acsmedchemlett.9b00578]

Source